Hologic Inc. (NASDAQ:HOLX) finished Wednesday with a subtraction of -$1.55 to close at $75.31, a downside of -2.02 percent. An average of 2,456,220 shares of common stock have been traded in the last five days. There was a gain of $1.68 in the past week, and it reached a new high 17 times over the past 12 months. The last 20 days have seen an average of 2,078,855 shares traded, while the 50-day average volume stands at 1,803,966.
HOLX stock has decreased by -7.56% in the last month. The company shares reached their 1-month lowest point of $72.82 on 08/01/23. With the stock rallying to its 52-week high on 05/01/23, shares of the company touched a low of $59.78 and a high of $87.88 in 52 weeks. It has reached a new high 11 times so far this year and achieved 0.67% or $0.50 in price. In spite of this, the price is down -14.30% from the 52-week high.
Insider Transactions
HOLX stock investors should be aware that Hologic Inc. (HOLX) stock had its last reported insider trading activity 70 days ago on Jun 15. In this transaction, the insider spent $797,240. Div. President, GYN Surgical, Mitchell Essex D, disposed of 2,390 shares at a price of $83.73 on May 05. The insider now owns more than $200,115 worth of shares. Prior to that, Principal Accounting Officer COHN BENJAMIN JORDAN went on to Sale 9,128 shares at $85.28 each on Feb 07. An amount of $778,445 was transacted.
Valuation Metrics
Hologic Inc. (HOLX) has a trailing price-to-earnings (P/E) ratio of 38.98. The stock’s beta is 1.00. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 4.62, the price-to-book (PB) ratio at 3.59, and the price-to-cash flow ratio at 22.43.
Financial Health
The quick ratio of Hologic Inc. for the three months ended June 29 was 3.70, and the current ratio was 4.40, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.54 and a total debt to equity ratio of 0.55 for the quarter ending June 29. Hologic Inc.’s EBITDA margin for the year ending June 29 is 42.74%, while its operating margin for the same period stands at 16.80%. Its gross profit as reported stood at $3.0 billion compared to revenue of $4.86 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Hologic Inc.’s return on assets was 5.20%.
Earnings Surprise
For the three-month period that ended June 29, Hologic Inc. had $2.79 billion in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$40.5 million in the quarter, while revenues of $218.5 million were grew 663.95%. The analyst consensus anticipated Hologic Inc.’s latest quarter earnings to come in at $0.89 per share, but it turned out to be $0.93, a 4.50% surprise. For the quarter, EBITDA amounted to $82.6 million. Shareholders own equity worth $244.94 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Hologic Inc. (HOLX) price momentum. RSI 9-day as of the close on 23 August was 46.46%, suggesting the stock is Neutral, with historical volatility in this time frame at 24.31%.
As of today, HOLX’s price is $74.91 +2.28% or $1.68 from its 5-day moving average. HOLX is currently trading -8.05% lower than its 20-day SMA and -6.45% lower than its 100-day SMA. However, the stock’s current price level is -4.01% below the SMA50 and +2.78% above the SMA200.
The stochastic %K and %D were 65.91% and 46.98%, respectively, and the average true range (ATR) was 1.58. With the 14-day stochastic at 54.85% and the average true range at 1.56, the RSI (14) stands at 44.44%. The stock has reached 0.96 on the 9-day MACD Oscillator while the 14-day reading was at 0.50.
Analyst Ratings
Needham upgraded Hologic Inc. (NASDAQ: HOLX) to a a Buy rating in its most recent analyst report. Previously, the stock was rated as a Hold.
